News
Drugs to prevent versus those to treat migraine might not share targets
The distinct molecular events in each phase of migraine suggest the prevention and treatment targets differ.
News
Nail psoriasis in Black patients often overlooked
Clinical training might explain the delay in diagnosis of nail psoriasis in patients with darker skin types.
News
At 52 weeks, complete hair regrowth rates still climbing on deuruxolitinib
Complete responses continued to increase in open-label extensions of phase 3 alopecia areata studies.
News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
News
Hidradenitis suppurativa: Two anti-IL17A/F therapies yield positive results
Two biologics that inhibit both IL-17A and 17F effectively controlled hidradenitis suppurativa in phase 3 trials.
News
AI interpretation of CCTA unlocks value of inflammation as CV risk factor
Combined with imaging, artificial intelligence (AI) identifies risk in setting of nonobstructive coronary disease.
News
Parent concerns a factor when treating eczema in children with darker skin types
For the parent, the pigmentation changes, rather than the inflammation, might be the governing issue and the reason that he or she brought the...
News
Adolescents with migraine need smooth handoff to adult care
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Audio
Alternative antirejection regimen is efficacious in pediatric heart transplant
Results of the head-to-head TEAMMATE trial show the combination of everolimus and low-dose tacrolimus can be considered an alternative to MMF plus...
News
Avoid adding to minority stress when treating headache in LGBTQIA+ patients
To address headache in LBGTQIA+ patients, inclusive behavior can set the stage of collaboration toward control.
News
Pharmacist-based strategy places more patients on statins
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing...
News
For AFib cardioversion in obesity, dual energy might be the answer
In patients with obesity, dual energy cardioversion is more reliable and just as safe as conventional single energy cardioversion as an initial...
News
Sustained reductions in Lp(a) achieved with novel siRNA drug
“At the highest doses, lepodisiran is not just lowering Lp(a), it appears to be getting rid of it.”
News
Angioplasty finally proven beneficial in stable angina: ORBITA-2
“I can say with confidence on the basis of a placebo-controlled trial that PCI certainly does have a favorable impact in patients with documented...
News
Prurigo nodularis diagnosis delay in skin of color gains added significance
Given the expanding array of therapies, the message of considering prurigo nodularis in Black patients in order to accelerate the time to...